A potential vaccine for Alzheimer’s Disease has passed another stage of clinical trials
An Alzheimer’s vaccine, UB- 311, has entered the next phase of clinical drug trials. Memory loss, confusion, and subsequent problems with speech and understanding; these are all common symptoms of Alzheimer’s. It is a form of dementia affecting more than half a million people in the UK. With the Alzheimer’s Society...
Read More